A long-misunderstood condition affecting millions of women worldwide is getting a new name to improve awareness and diagnosis. The World Health Organization has announced that Polycystic Ovarian Syndrome (PCOS) will now be known as Polyendocrine Metabolic Ovarian Syndrome (PMOS).
Why the Name Change?
PCOS affects an estimated 10 to 13 percent of women of reproductive age globally. Experts say the old name placed too much emphasis on ovarian cysts, which are not always present, and failed to capture the full scope of the condition. The new name, PMOS, better reflects the metabolic and endocrine disruptions that underlie the syndrome.
Broader Health Implications
Dr. Alla Vash-Margita, associate professor at Yale University, explained, "By calling this condition polycystic ovary, we're missing the big picture." PMOS is linked not only to irregular menstrual cycles and fertility issues but also to insulin resistance, type 2 diabetes, cardiovascular disease, mental health conditions, and other metabolic impacts.
Hope for Better Care
Health experts believe the renaming will reduce stigma, encourage early diagnosis, and promote a more holistic approach to treatment across different medical fields. The change is expected to help patients and healthcare providers understand the condition as a systemic metabolic disorder rather than solely a reproductive issue.
